Obinutuzumab in Treatment of Fibrillary Glomerulonephritis

Conditions: Fibrillary Glomerulonephritis Interventions: Drug: Obinutuzumab Sponsors: Mayo Clinic Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials